By Claire Asher Plastic pollution is among the gravest environmental crises facing humanity. Plastic production since 1950 ...

Texxon Holding Limited annonce que son usine de production de polystyrène située dans le Henan a officiellement débuté ses opérations en juin 2026. Ce lancement marque l'achèvement du ...

Alternatiba Haïti, exige l’application de l’arrêté du 10 juillet 2013 interdisant la production, l’importation, la ...

Le Ministère de la Défense informe que le processus de sélection d’une nouvelle promotion de soldats des Forces Armées ...

Solid diamonds may be forming and falling like rain deep inside Neptune and Uranus, where pressures exceed 19 gigapascals and temperatures climb high enough to rip methane molecules apart. Laboratory ...

The fundamental problem with recycling plastic through chemical breakdown has always been selectivity. When plastic is melted or heated, the result is a disorganised mix of gases, wax, tar, char, and ...

Engineers have modeled a new way to recycle polystyrene that could become the first viable way of making the material reusable. Engineers have modelled a new way to recycle polystyrene that could ...

British company Carbon Cell has used agricultural waste to make a carbon-negative and compostable alternative to polystyrene packaging and building insulation that avoids contributing to plastic ...

The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...

From its accidental discovery in a German apothecary shop in 1839 to becoming one of the world's most versatile and widely produced plastics, polystyrene has shaped modern manufacturing, packaging, ...

Used plastic plates, cups, forks, spoons, napkins, and bottles strewn about a grassy area Although polystyrene consumer products are incredibly common, the economics of recycling means most of this ...

The star of Monday’s deal is gusacitinib, a small-molecule drug that Formation is developing for chronic hand eczema. Sanofi will explore additional indications for gusacitinib in a Phase I study.